Local Institution
Longueuil, Quebec J4N 1L6
0 studies enrolling now · 12 studies all time
What they study most
Acute Coronary Syndromes, Albuminuria, Atrial Fibrillation, Atrial Flutter, Congestive Heart Failure, Diabetes Mellitus, Diabetes Mellitus II, Diabetes Mellitus, Type 2, Diabetes, Type 2, Type 2 Diabetes, Type 2 Diabetes Mellitus
Studies at this site
- A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart — Completed
- Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation — Completed
- A Pilot Study of BMS-512148 in Subjects With Type 2 Diabetes — Completed
- Study Assessing Saxagliptin Treatment In Type 2 Diabetic Subjects Who Are Not Controlled With Metformin Alone — Completed
- Irbesartan in Heart Failure With Preserved Systolic Function (I-Preserve) — Completed
- Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise — Completed
- PPAR - Combination With Metformin — Completed
- A Trial to Evaluate BMS-298585 as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control — Completed
- Irbesartan Versus Placebo in Combination With Ramipril for Treatment of Albuminuria — Completed
- Study Comparing Muraglitazar With Glimepiride in Type 2 Diabetics Who Are Not Controlled With Metformin Alone — Completed
- Study of Muraglitazar Versus Pioglitazone in Type 2 Diabetes — Completed
- Dose Ranging Study With LT, Monotherapy, PPAR — Completed